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Abstract
Background: Nowadays, there are very few studies about massive transfusion in our country. 
This situation generates the necessity to the elevation of possible new strategies to diminish 
mortality and its adverse effects.
Material and methods: All massive transfusions were evaluated in a retrospective way from 
October 2010 to October 2012. All diagnosis groups were recorded and the patients were divid-
ed into three groups depending on the ratio between packed red blood cells (PRBC) and fresh 
frozen plasma (FFP) units (ratios ≤2, >2, and without FFP). Their mortality and/or survival were 
evaluated 30 days after as well as all the factors associated with the event.
Results: A total of 69 patients were included (37 trauma patients, 28 gunshot wounds and 4 with 
lacerated wounds); the groups (ratios ≤2, >2, and no plasma at all) were distributed as follows: 
30, 30 and 9 patients each, with an overall mortality rate of 60.8% within 30 days. A lower sur-
vival rate (12%) in the no plasma group (P=.015) was found and systolic blood pressure during 
transfusion had a mean of 67.7 mmHg (P=.012) in this group. Fresh frozen plasma units were 136 
and 249 for >2 and ≤2 ratios respectively (P<.01); 85.5% of all patients developed metabolic 
acidosis during the transfusion, and the number of days in the hospital after the event had a 
mean of 24.5 days in all patients.
Conclusions: High rates of massive transfusion mortality are still being reported in our ield. The 
use of transfusion strategies contribute to elevate the survival rate in patients with massive 
transfusion treatment.
© 2014 Revista Medicina Universitaria. Facultad de Medicina UANL. Published by Elsevier México. All rights 
reserved. 
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Introduction
The need for massive transfusion in an acute hemorrhage is 
catalogued as one of the most important risk factors for 
death among multiple trauma patients.1 Massive transfusion 
is deined as the reposition of the blood volume in 24 h or 7% 
of the ideal weight in adults or 9% in children; however, 
there are different definitions like a replacement higher 
than 50% of the blood volume in 3 h, or more practical dei-
nitions like the transfusion of over 4 PRBC in 1 h, or over 
10 units of PRBC in a period of 24 h.2
In the irst studies in which massive transfusion was linked 
to mortality the numbers were close to 90%,3 even nowadays 
rates between 30% and 70% continue to be reported.4,5 There-
fore, massive hemorrhage morbi-mortality remains unaccept-
ably high, and thus new therapeutic schemes have been 
suggested in the last decade with the purpose of increasing 
survival.6 The institution of these massive transfusion proto-
cols has brought benefits and they have been attributed 
mainly to keeping a close or equivalent ratio to fresh frozen 
plasma (FFP) in relation to red blood cells (RBC) transfused.7
Even though each hemoderivate has precise indications, 
the circumstances of the bleeding (with or without tissue 
damage) determine the different transfusion thresholds.8 
One of the main challenges in the timely reinstitution with 
hemocomponents is also the identiication of the patient 
who will have massive transfusion and the prediction of 
transfusion requirements.9
Nowadays the frequency of massive hemorrhages in our 
country varies greatly and there are few studies in our ield, 
which conirms the need to institute these protocols. Few 
institutions have standardized massive transfusion proto-
cols. The objective of the present study is to describe mor-
tality and the use of RBC:FFP ratio in trauma patients 
subject to massive transfusion, as well as to detect factors 
associated with morbidity and mortality.
Materials and methods
A retrospective analysis of acute hemorrhage patients with-
in the shock-trauma area was performed. Patients who had 
transfusions of 10 or more PRBC in a period of less than 24 h 
from october 1st 2010 to october 30th 2012 were evaluated. 
Acute hemorrhage and massive transfusion patients were 
recruited through the blood bank’s CiBank V1.0® (TDI) op-
erative system, excluding patients who were under 15 years 
old, patients with neoplastic diseases, and patients with 
previous chronic diseases. RBC:FFP ratio was obtained for 
each case (i.e. 10 RBC + 5 FFP = 10 / 5 = 2 ratio) and the popu-
lation was divided into three different groups, those with an 
RBC:FFP rate ≤2, another group where the RBC:FFP ratio 
was >2 and a third group which did not receive FFP during 
massive transfusion. Patients’ characteristics were de-
scribed according to age, gender and diagnosis (admission 
and injury), both diagnoses were evaluated in percentage 
and divided according the type of injury: vital organ injury 
grades 3 to 5 according to the American Association for the 
Surgery of Trauma Organ Injury Scale,10 severe head injury 
(SHI), larger-caliber vessel and other injuries. This last group 
was formed by patients with multiple fractures and limb am-
putations. Mortality and/or survival rates after 30 days and 
the amount of in-patient days after the event were evalu-
ated. Factors associated with the hemorrhagic event, like 
systolic blood pressure (SBP) during transfusion and the 
presence of metabolic acidosis, as well as the number of 
PRBC and fresh frozen plasmas transfused, were analyzed. 
A chart representing survival rates up to 30 days after the 
event was created using the Kaplan-Meier curve, and an 
evaluation of the difference between groups using the log-
rank test was performed, using mean and median as central 
tendency measurements and standard deviation and inter-
quartile ranges as dispersion measurements. The x2 test was 
used for qualitative variables, and one-way ANOVA was used 
for differences between groups in the case of three groups. 
The Mann-Whitney U test was used as well in the case of 
two groups with a non-parametric distribution. The SPSS 
v.20 statistical program was used. 
Results
A total of 83 registries of patients with massive transfusions 
were obtained, excluding 9 patients with neoplastic diseas-
es, 4 with previous chronic disease, and 1 younger than 
15 years old. A total of 69 patients were included in the 
study with admission diagnoses distributed as follows: 37 
trauma patients, 28 gunshot wounds and 4 with lacerated 
wounds. The average age was 33 years old, the majority of 
whom were male (84%). The groups were divided as follows: 
groups’ ratios ≤2 with 30 patients, ratios >2 with 30 patients 
and the no-plasma group with 9 patients (table 1). Diagno-
ses according to the type of injury and their comparison 
between groups are shown in tables 2 and 3. Mortality at 
30 days resulted in 56.6% for the ratio ≤2 group just as in the 
ratio >2 group with 56.6% and 88% for the group without FFP 
(figure 1); obtaining an overall mortality of 60.8%. A dis-
tinctly lower survival rate of 12% was observed during the 
irst 24 h in the group of patients who did not receive FFP 
(P=.015) showing a signiicant difference with respect to the 
other groups. The other two groups (>2 and ≤2) showed no 
differences (igure 1). Systolic blood pressure during trans-
fusion within the no-plasma group had a mean of 67.7 mmHg 
proving a difference from the other two groups (P=.012) 
which presented means of 90 and 92 mmHg (table 1). 85.5% 
of the patients presented metabolic acidosis during the 
transfusion. The mean for the amount of in-hospital days 
was 24.5, without a signiicant difference among the groups, 
keeping in mind that in the no-plasma group only 1 patient 
survived longer than 24 h thus he was not included in the 
Days of hospital Stay (DOHS) analysis. 
Regarding transfusions, 136 units were transfused for the 
>2 group and 249 units for the ≤2 group (P<.01) with means 
of 4.5 and 8.3, and medians of 4 and 7.5 respectively 
(P<.01). RBC transfusion did not show signiicant difference 
between the groups (P=.748) (table 1).
Discussion
Nowadays high mortality rates related to massive transfu-
sions are still reported in our ield. Therefore, we suggest 
through this study the use of FFP in massive transfusions, 
the above as a consequence of obtained results of different 
RBC:FFP ratios which suggest that FFP transfusion in similar 
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amounts to RBC transfused could improve survival rates at 
24 h and at 30 days after the hemorrhagic event. In our sur-
vival chart at the end of follow-up there wasn’t a statisti-
cally signiicant difference between the >2 group and the ≤2 
group, we can see a slight tendency favoring survival rates 
in the ≤2 RBC:FFP ratio, but this could be a result of 5 of the 
patients in the ratio >2 group having a severe head injury 
diagnosis (table 2) which may cause a bias in this tendency.
It is dificult to afirm the participation of FFP in the he-
modynamic state of these types of patients, however look-
ing at our results and the differences regarding SBP between 
the no-plasma group and the other two groups, and knowing 
the role FFP plays in reducing endothelial vascular permea-
bility in patients with hemorrhagic shock,11 suggests its im-
plication as a helper in hemodynamic stabilization of 
massive hemorrhage patients.
Additionally we stress the importance of the identiica-
tion of metabolic deterioration, such as acidosis, present in 
most patients who undergo massive transfusion, knowing 
that patients at the beginning of crystalloid reanimation are 
administered large volumes of isotonic saline solution 
(Na+Cl– 0.9%) with the purpose of expanding intravascular 
volume in massive bleeding, conditioning us to a hyperchlo-
remic metabolic acidosis.12
Table 1 Characteristics and associated variables
No FFP Ratio >2 Ratio ≤2 Total (%) P-value
Total patients 9 30 30 69 (100)
Male 9 26 23 58 (84) .214
Age (years), median 35 (30-41) 34 (24-46) 24.5 (21-40) 33 .38
PRBC, mean 115 (12.7) 368 (12.3) 390 (13) 873 .748
PRBC, median 13 (11-14) 11 (10-15) 11.5 (10-30) —
FFP, (mean) — 136 (4.5) 249 (8.3) 385 <.01
FFP, median — 4 (4-5) 7.5 (6-10) —
SBP mmHg median 65 (60-75) 90 (80-100) 90 (80-100) 90 (80-100) .012
SBP mmHg mean 67.7 92 90 93.3
Metabolic acidosis, % 66.6 83.3 93.3 85.5 .12
DOHS, mean 30* 25.6 23.5 24.5 .95
DOHS: days of hospital stay; FFP: fresh frozen plasma; PRBC: packed red blood cells; SBP: systolic blood pressure.
*DOHS of the only patient which survived in the no FFP group.
Table 2 Injuries of deceased patients
Type of injury Ratio ≤2 Ratio >2 No FFP Total (%)
Vital organa (grade III-V) 7 4 3 14 (33.3)
Severe head injury 1 5 1 7 (16.6)
Vascularb 5 4 3 12 (28.5)
Other 4 4 1 9 (21.4)
Total 17 17 8 42
aExcluding brain injury.
bLarge vessels.
Table 3 Injuries of living patients
Type of injury Ratio ≤2 Ratio >2 No FFP Total (%)
Vital organa (grade III-V) 4 7 1 12 (44.4)
Severe head injury 2 2 (7.4)
Vascularb 5 2 7 (25.9)
Other 4 2 6 (22.2)
Total 13 13 1 27
aExcluding brain injury.
bLarge vessels.
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Currently in Mexico the guidelines for massive transfusions 
suggest the administration of the blood components in deicit 
according to the patient’s clinical evolution and the results of 
the coagulation tests,13 thus through this study we promote 
an update of the guidelines with a reference to massive 
transfusions. On the other hand, international studies suggest 
sticking as closely as possible to a 1:1 ratio (RBC:FFP) in order 
to reduce mortality at least in the irst 24 h.14
Therefore, after having identiied in this document the 
main risks of the patients undergoing massive transfusions 
in our hospital, we also suggest the institution of standard-
ized protocols which closely stick to international transfu-
sion guidelines. It is important to note that the use of FFP is 
relevant for the attention of these patients and acknowl-
edging the challenge that the prediction of the use of time-
ly restitution with hemoderivatives implies, we recommend 
the use of prediction scores like the TASH as part of the al-
gorithm for massive hemorrhage diagnosis,15 as well as the 
use of thawed plasma with the purpose of shortening the 
availability times of said component,16 moreover it is neces-
sary to insist on the need of prospective studies with vari-
able adjustment like the severity of the injury in trauma 
patients. Massive transfusion is in many cases inevitable; 
recognizing the risk that comes along with this practice al-
lows us to establish a treatment preventive protocol in 
which fresh plasma seems to play a very important role. 
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Figure 1 Kaplan-Meier survival 
curve. FFP: fresh frozen plasma.
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